Clinical Trial Update: A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing ezetimibe plus simvastatin to simvastatin alone in patients at risk for coronary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Disease

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Organon and Co | Conditions: Coronary Disease | Phase 3 | Status: COMPLETED